Very proud of this #ClinicalTrial of Cabozantinib/Nivolumab #CaboNivo & Cabozantinib/ Nivolumab/Ipilimumab #CaboNivoIpi published Journal of Clinical Oncology, that includes #rareGUtumors & took years to complete but laid the foundation for many future trials in oncology gcc02.safelinks.protection.outlook.com/?url=https%3A%…

👋Welcome to Ohio State Medical Oncology, Fuat Bicer MD, PhD. We look forward to working with you!

Thank you Journal of Clinical Investigation for the shoutout. This work showed that Tregs play a dominant role in promoting CD8+ T cell exhaustion in the tumor - a finding that I hope will have both basic and practical implications. Kudos to all the authors Pelotonia Institute for Immuno-Oncology, X-less and otherwise.

Proud to announce that The Ohio State University College of Medicine was named a top-tier medical school in the nation for research by @USNews! With a reputation for innovative education, life-changing research and extraordinary care, #OSUCOM is leading the way.

Pelotonia 2024 kicks off August 2 & we are amped! On behalf of PIIO Founding Director Zihai Li, MD, PhD Li, & the members of Team Buckeye - PIIO, special thanks to all the riders, challengers, and volunteers who make this event possible. We are passionate about ENDING #CANCER!

"Scientists need more time to think" ➡️This perspective speaks to me! 💯 -Administrative bloat, email overuse, meetings for meetings...pull time away. Finding time to think is very hard...but essential. 🤔 nature.com/articles/d4158…

New research by #PIIO members denkolab, Qin Ma BMBL, Dan Spakowicz in Cancer Research Communications found that models for predicting prolonged survival with #immunotherapy using both #microbe abundances and #GeneExpression outperformed models using either dataset alone. Read more here:

Thanks to all of our ⁦Pelotonia⁩ volunteers for an amazing 2024 ride! Watch out kidney cancer…⁦Eric A. Singer, MD, MA, MS, FACS, FASCO⁩ and ⁦Elshad Hasanov, MD, PhD⁩ are coming for you. #EndingCancer ⁦The Ohio State University Wexner Medical Center⁩ ⁦The James⁩ ⁦Ohio State Wexner Medical Center Urology Dept.⁩ ⁦Pelotonia Institute for Immuno-Oncology⁩

She finished rounding on inpatient service and I finished my first 20 miles riding towards the same #onegoal #cancerfreeworld Pelotonia The James Pelotonia Institute for Immuno-Oncology Ohio State Medical Oncology Team Buckeye #BikeforBrainMetastasis pelotonia.org/profile/EH9087… pelotonia.org/peloton/a0sQj0… Thank

What a day and ride! Feeling proud and inspired by the incredible Pelotonia community and cause #onegoal #creatingcancerfreeworld The James Ohio State Medical Oncology Ohio State Wexner Medical Center Urology Dept. every mile brings us closer to conquering cancer! pelotonia.org/profile/EH9087…

Grateful to be on this ride and mission together with you Eric A. Singer, MD, MA, MS, FACS, FASCO #kidneycancerfreeworld KidneyCAN IKCC Kidney Cancer Kidney Cancer

‼️New research on immune checkpoint inhibitors reveals that higher peak corticosteroid doses for immune-related adverse events (irAEs) are linked to worse survival outcomes. ➡️➡️This post hoc analysis across six international trials suggests a need to reconsider irAE management

Thanks to OSU Hematology The James for the warm welcome to the Division. Honored to be part of an outstanding group of professionals! Thanks to Dr Verschraegen for her commitment and terrific job in the last 7 years, thrilled to work all together! Ohio State

Our first lab dinner at Istanbul Restaurant Dublin was a feast for both the stomach and the soul! 🍽️ Grateful to have this incredible team by my side—we’re just getting started, and the future looks bright! Can’t wait to see their growth, success stories and contributions for

It doesn’t happen by accident. s.hbr.org/3nJ3dUc

What a wonderful weekend spent together with Azerbaijani superstars! Ilaha Isali Thanks to #AAMA for organizing this meeting and huge thanks to my wonderful mentor - Dr. Hasanov - for the opportunity to represent our amazing Elshad Hasanov, MD, PhD team! 🤩

Very interesting data on ctDNA using a methylation algorithm to predict response in pts with ES-SCLC presented by Jinesh Gheeya, MD, PhD and our colleagues at #WCLC24 Congrats! The James David Carbone MD Dwight Owen Carolyn Presley, MD MHS Ohio State Medical Oncology IASLC

Paper out- TLX-250cdx as a tool to help patients with renal masses! also excited to have high risk postop staging protocol open too (Canine). UCLA Urology . Kidney Cancer KCCure KidneyCAN Kidney Cancer Canada YUO thelancet.com/journals/lanon… clinicaltrials.gov/study/NCT06447…

Dr. Akkaya's research lab in full swing #osuwexmed #rheumatology #rhuem #bcells #research #researchlab #immunology #immunologyresearch